KD Pharma Group invests in Nutriceutical Holdings

© iStock/Kritchanut
© iStock/Kritchanut

Related tags Nutrition

Omega-3 producer KD Pharma will become the largest shareholder in Nutriceutical Holdings (NH), parent company of Physician Recommended Nutriceuticals (PRN) and Veterinarian Recommended Solutions (VRS).

The agreement also gives KD Pharma, the third largest omega-3 producer in the world,​ the option to acquire all of NH, a leading producer of omega-3 nutraceuticals via its PRN​ and VRS​ brands.  

“We believe we have found the ideal partner in KD. They are committed to growing the NH companies by providing us with supply chain certainty and superior Omega-3 manufacturing technology that can help us excel within a competitive Omega-3 landscape,”​ said PRN CEO, Ken Krieg. “We are pleased to have a capital partner that shares our vision for growing PRN and VRS.”

Oscar Groet, KD Pharma CEO, added: “We are extremely excited to be partnering with a fast-growing company that shares our passion for product excellence.  The investment in NH gives KD growth opportunities in two rapidly growing markets for Omega 3, eye and animal health”

Related news

Show more

Related products

show more

Stay one step ahead in the collagen market

Stay one step ahead in the collagen market

Content provided by Bioiberica | 26-Feb-2024 | White Paper

It's no secret that interest in collagen is at an all-time high – especially for joint health. This presents a real opportunity for manufacturers...

Krill oil supports six key areas of healthy aging

Krill oil supports six key areas of healthy aging

Content provided by Aker BioMarine | 14-Feb-2024 | White Paper

The global population is getting older—according to WHO by 2050 the world’s population over 60 years will double and the population above 80 years will...

Consumers' growing demand for Omegas

Consumers' growing demand for Omegas

Content provided by Fruit d'Or | 13-Feb-2024 | White Paper

Consumers are increasingly interested in the benefits of omegas supplements. According to forecasts for 2023–2030, the global omega-3 market is expected...

Related suppliers

Follow us

Products

View more

Webinars